Cite

    Ida Pernicova et al.. “Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial.” Lancet, vol. 8, no. 4, 2020, pp. 278–291. http://access.bl.uk/ark:/81055/vdc_100120046835.0x000005